Lifecore Biomedical, Inc., headquartered in the United States, is a prominent player in the biotechnology industry, specialising in the development and manufacturing of innovative medical devices and biopharmaceuticals. Founded in 1984, the company has achieved significant milestones, including advancements in its core product lines, which focus on hyaluronic acid-based solutions for various medical applications. With a strong presence in the orthopaedic, ophthalmic, and aesthetic markets, Lifecore is recognised for its commitment to quality and precision. The company’s unique offerings, such as its proprietary manufacturing processes, set it apart from competitors, ensuring high standards and efficacy. Lifecore Biomedical continues to solidify its market position through strategic partnerships and a dedication to research and development, making it a trusted name in the biomedical field.
How does Lifecore Biomedical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Lifecore Biomedical, Inc.'s score of 13 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Lifecore Biomedical, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or climate commitments outlined. Without concrete figures or established initiatives, it is challenging to assess their carbon footprint or climate strategy. However, as a player in the biomedical industry, Lifecore is likely aware of the growing importance of sustainability and may be exploring avenues to align with industry standards for emissions reduction and climate action. Further information on their commitments or initiatives may be necessary to provide a comprehensive overview of their environmental impact.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Lifecore Biomedical, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.